Logo
x

Search category

Subscribe Now

DCR-LIV2

Boehringer Ingelheim to Develop Dicerna's GalXC RNAi Candidate for NASH

Boehringer Ingelheim to Develop Dicerna's GalXC RNAi Candidate for NASH

  • May 25, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.